Endovasc lists on Berlin stock exchange:
This article was originally published in Clinica
Executive Summary
Endovasc is to list on the Berlin stock exchange in an attempt to increase its visibility in Europe, the Montgomery, Texas company says. "The Berlin stock exchange boasts the world's leading and most interesting stocks, including a number of high-potential market hopefuls, a niche into which we feel our company fits very comfortably," said Dr David Summers, Endovasc's CEO. Endovasc has a stent-coating technology as well as a biodegradable/resorbable stent.